Mahata SK. is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart. Am J Physiol Heart Circ Physiol 295: H113-H122, 2008. First published May 9, 2008 doi:10.1152/ajpheart.00172.2008.-The catecholamine release-inhibitory catestatin [Cts; human chromogranin (Cg) A 352-372, bovine CgA344-364] is a vasoreactive and anti-hypertensive peptide derived from CgA. Using the isolated avascular frog heart as a bioassay, in which the interactions between the endocardial endothelium and the subjacent myocardium can be studied without the confounding effects of the vascular endothelium, we tested the direct cardiotropic effects of bovine Cts and its interaction with ␤-adrenergic (isoproterenol, ISO) and endothelin-1 (ET-1) signaling. Cts dosedependently decreased stroke volume and stroke work, with a threshold concentration of 11 nM, approaching the in vivo level of the peptide. Cts reduced contractility by inhibiting phosphorylation of phospholamban (PLN). Furthermore, the Cts effect was abolished by pretreatment with either nitric oxide synthase (N G -monomethyl-Larginine) or guanylate cyclase (ODQ) inhibitors, or an ET B receptor (ET BR) antagonist (BQ-788). Cts also noncompetitively inhibited the positive inotropic action of ISO. In addition, Cts inhibited the positive inotropic effect of ET-1, mediated by ET A receptors, and did not alter the negative inotropic ET-1 influence mediated by ET BR. Cts action through ET BR was further suggested when, in the presence of BQ-788, Cts failed to inhibit the positive inotropism of both ISO and ET-1 stimulation and PLN phosphorylation. We concluded that the cardiotropic actions of Cts, including the ␤-adrenergic and ET-1 antagonistic effects, support a novel role of this peptide as an autocrineparacrine modulator of cardiac function, particularly when the stressed heart becomes a preferential target of both adrenergic and ET-1 stimuli. chromogranin A; myocardial contractility; inotropic agents; avascular heart; endocardial endothelium CHROMOGRANIN A (CgA), an acidic secretory proprotein, is the chromogranin/secretogranin protein family's index member (24, 53, 57) . CgA proteolytic processing gives rise to several peptides of biological importance, including such counterregulatory agents as the dysglycemic hormone pancreastatin (52), vasodilator vasostatin 1 (VS-1) (2), and catecholamine releaseinhibitory peptide catestatin (Cts; human CgA 352-372 , bovine CgA 344-364 ) (35-40). Plasma CgA levels and epinephrine levels are increased in patients with essential hypertension or heart failure (15), whereas Cts plasma levels are significantly lower (44), suggesting that Cts has an inhibitory effect on chromaffin cells in vivo. Consistent with human studies, genetic ablation of the CgA gene (Chga) results in high blood pressure in mice (34), and the high blood pressure in ChgaϪ/Ϫ mice can be rescued either by pretreatment with Cts or introduction of the human CgA gene (CHGAϩ/ϩ) in the mice ChgaϪ/Ϫ background by bacterial artificial chromosome (BAC) transgenic technology. Furthermore, low Cts levels predict augmented adrenergic responses to stressors (44), suggesting that a reduction in Cts may increase the risk of hypertension.
, suggesting that Cts has an inhibitory effect on chromaffin cells in vivo. Consistent with human studies, genetic ablation of the CgA gene (Chga) results in high blood pressure in mice (34) , and the high blood pressure in ChgaϪ/Ϫ mice can be rescued either by pretreatment with Cts or introduction of the human CgA gene (CHGAϩ/ϩ) in the mice ChgaϪ/Ϫ background by bacterial artificial chromosome (BAC) transgenic technology. Furthermore, low Cts levels predict augmented adrenergic responses to stressors (44) , suggesting that a reduction in Cts may increase the risk of hypertension.
It has recently been reported that human recombinant CgA (10 -100 nmol/l) stimulates the release of endothelin (ET; by ϳ4-fold) from human vein endothelial cells, suggesting interaction between the sympathochromaffin system and the endothelium (29) .
We have shown previously that the NH 2 -terminal CgA fragment VS-1 exerts profound myocardiosuppressive and antiadrenergic action in frog, eel, and rat hearts (54, 17, 25, 16) . Unlike in eel (25) and rat (20) , in frog, the VS-1-induced negative inotropism appears independent from the endocardial endothelium (EE) and the nitric oxide (NO)-cGMP pathway, indicating species-and tissue-specific targets and signaling mechanisms (17) . Of note, in the eel and frog hearts, the VS-1-induced negative inotropism is abolished by Ca 2ϩ and K ϩ channel antagonists and inhibitors of cytoskeletal reorganization (42) . Similarly, involvements of either Ca 2ϩ and K ϩ channels or cytoskeleton rearrangement appear also involved in VS-induced changes detected in vascular preparations (1, 8) or pulmonary and coronary arterial endothelial cells (5) , respectively. These findings imply that the highly conserved NH 2 -terminal VS-1 domain of CgA modulates cardiovascular functions at least in three classes of vertebrates. Interestingly, another remarkable vasoreactive (26) and antihypertensive (34) peptide, Cts, is present in the COOH-terminal domain of CgA, but nothing is known regarding the direct cardiac actions of Cts. We hypothesized that this fragment could also act as a cardioactive agent modulating heart performance both under basal and stimulated conditions. If our hypothesis proves to be correct, then CgA would further epitomize that the processing of more than one peptide from a single prohormone rather than from two precursors may be homeostatically advantageous provided both peptides regulate the same physiological response. Therefore, in the present study, we investigated Cts' direct cardiotropic action and the possible EE-NO-cGMP pathway involvement, as well as Cts' counteracting actions against both ␤-adrenergic and ET-1-elicited stimulations. We used the isolated working frog heart, which allowed a hemodynamic evaluation independent from coronary reactivity and extrinsic neuronal and endocrine influences. In fact, in the hearts of homeotherms (e.g., mammals), the coronary vascular endothelium and EE act in concert to modulate humorally myocardial activity, making EE contribution in the paracrine regulation of myocardial function difficult to define (10) . In contrast, in the avascular frog heart, EE is the only barrier between the superfusing blood and the subjacent myocardial microenvironment and is therefore a unique model to analyze its autocrine/ paracrine role in the transduction of blood-borne endoluminal chemical stimuli that can target the myocardium (21) .
On the whole, the data suggest a new role of Cts in cardiac physiology, particularly under conditions of heightened neuroendocrine activation and consequent myocardial damage.
MATERIALS AND METHODS

Isolated and Perfused Working Heart Preparation
Frog hearts were isolated from both male and female specimens of Rana esculenta (weighing 16 Ϯ 0.8 g) and connected to a perfusion apparatus as previously described (51) . Animal maintenance and experimental procedures approved by the Italian University Minister were in accordance with the Guide for the Use and Care of Laboratory Animals (European Communities Council Directive 1986). Efforts were made to minimize animal suffering and reduce the number of species used. Experiments were performed at room temperature (18 -20°C) . A Grass S44 stimulator was used to electrically stimulate and pace heart preparations with single pulses of 20 V for 0.1 s. The stimulation rate was identical to that of the control, unpaced rate. The hearts were perfused with saline that was equilibrated with air and was composed (in mM) of 115 NaCl, 2.5 KCl, 1.0 CaCl 2, 2.15 Na2HPO4, 0.85 NaH2PO4, and 5.6 glucose. The buffer pH was adjusted to 7.30 -7.35 by the addition of Na2HPO4.
Measurements and Calculations
Pressures were measured through two MP-20D pressure transducers (Micron Instruments, Simi Valley, CA) that were connected to a PowerLab data acquisition system and analyzed using Chart software (ADInstruments, Ugo Basile, Comerio, Italy). Pressures were expressed in millimeters mercury and corrected for cannula resistance. The afterload (mean aortic pressure) was calculated as 2/3 diastolic pressure ϩ1/3 maximum pressure. Cardiac output (CO) was collected over 1 min and weighed. The CO was corrected for fluid density and expressed as volume measurements (ml/min) that were normalized to the wet body weight in kilograms. Stroke volume [SV, CO/heart rate (HR)], at constant pre-and afterload in paced hearts, was used as a measure of ventricular performance (i.e., as an index of inotropism). Ventricular stroke work (SW), an index of systolic functionality, was calculated (in mJ/g) as (afterload-preload, mmHg) ϫ SV (ml)/ventricle weight (g).
Drugs and Chemicals
Bovine Cts (bCgA peptide was synthesized by the solidphase method, using 9H-(f)louren-9-yl(m)eth(o)xy(c)arbonyl protection chemistry, as previously described (37) . Peptides were purified to Ͼ95% homogeneity by preparative reverse-phase HPLC (RP-HPLC) on C-18 silica columns. Authenticity and purity of peptides were further verified by analytical chromatography (RP-HPLC), and electrospray-ionization or matrix-assited laser desorption/ionization mass spectrometry. Isoproterenol (ISO), ET-1 (human porcine), the ET AR inhibitor BQ-123 sodium salt [cyclo(D-Asp-Pro-D-Val-Leu-D-Trp)], the ET BR inhibitor BQ-788 sodium salt (N-cis-2,6-dimethylpiperidinocarbonyl-L-gamma-methylleucyl-D-I-methoxycorbonyltryptophanyl-D-norleucine, Na), the nonspecific nitric oxide synthase (NOS) inhibitor N G -monomethyl-L-arginine (L-NMMA), the guanylate cyclase inhibitor ODQ [1H-(1,2,4) oxadiazolo-(4,3-a)quinoxalin-1-one], and Triton X-100 (t-octylphenoxypolyethoxyethanol) were purchased from Calbiochem. ISO, BQ-123, L-NMMA and Triton X-100 were prepared as stock solutions in double-distilled water; ET-1 was prepared in acetic acid; BQ-788 was prepared in methanol; ODQ was prepared in dimethyl sulfoxide and, being light sensible, used in a darkened perfusion apparatus to prevent degradation. Dilutions were made in Ringer solution immediately before use.
Experimental Protocols
Basal conditions. In all experiments, the minimal output pressure (diastolic afterload) was set at 29.5 mmHg, and the input pressure (preload) was regulated to obtain a CO of ϳ110 ml ⅐ min Ϫ1 ⅐ kg Ϫ1 (wet body wt) and are within the physiological range (51) . The heart generated its own rhythm. CO, HR, and pressures were measured simultaneously during the experiments. Hearts that did not stabilize within 10 -15 min from the onset of perfusion were discarded. These parameters are stable for Ͼ1 h (21) . All of the experiments were carried out within this period. To analyze the inotropic effects without confounding chronotropic action of substances, the preparations were electrically paced.
Drug application. After the 15-min control period, the hearts were perfused for 10 -15 min with Ringer solution enriched with increasing concentrations of either Cts (11-110 nM), ISO (0.1-1,000 nM), or ET-1 (0.01-10 nM) to generate concentration-response curves. Repetitive exposure of each heart to a single drug concentration revealed the absence of desensitization and the recovery from drug application after washing with Ringer (data not shown). Thus concentrationresponse curves were generated by perfusing cardiac preparations with increasing concentrations of the drug. The effects of ET-1 (0.01-10 nM) were also analyzed, exposing each heart preparation to a single concentration of the drug.
Cardiac signaling. Hearts were perfused with and without 110 nM Cts as before. At the end of the experiment, hearts were snap-frozen under liquid nitrogen and homogenized with 1 ml of ice-cold 0.2 M sucrose, Tris maleate (pH 7.0) buffer supplemented with 2 mM EDTA, pH 8.0, 1 mM sodium orthovanadate, 10 mM sodium pyrophosphate, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, 10 g/ml aprotinin, and 0.1 mM 3-isobutyl-1-methylxanthine. Sarcoplasmic reticulum (SR) membrane fractions were isolated from cytosolic proteins using methods described previously (50, 7) . Protein content was determined by Bradford assay (Bio-Rad), and 100 g of cytosolic protein were subjected to SDS-PAGE immunoblot analysis for phosphorylated (P)-extracellular signal-regulated kinase (ERK; Santa Cruz) and total ERK (Santa Cruz). For assessment of total phospholamban and phosphorylated PLN (P-PLN-Ser 16 ) levels, 20 g of SR membranes were subjected to electrophoresis, and the immunoblots were probed with anti-mouse PLN antibody (Affinity Bioreagents) and anti-P-PLN-Ser 16 .
Cts' effects on ISO stimulation.
To analyze the effects of Cts on the ISO response, Cts-stimulated hearts were perfused with Ringer containing a single concentration of Cts (33, 65, or 110 nM) plus ISO (10 nM) in the presence or absence of BQ-788 (1 M), an antagonist of ETBR. To further investigate the antagonistic action of Cts against the positive inotropic action of ISO, the concentration-response curve of ISO (from 0.1 to 1,000 nM) was performed in the presence of single concentrations of Cts (33, 65, or 110 nM). The time exposure to each drug concentration was 10 -15 min.
ET-1-or Cts-stimulated preparations.
To analyze the involvement of the EE and NOS-cGMP pathway in mediation of the effects of Cts and ET-1, hearts were perfused with ET-1 or Cts after pretreatment with Triton X-100 (0.05%), L-NMMA (NOS inhibitor, 10 M), and ODQ (guanylate cyclase inhibitor, 10 M).
For functional impairment of the EE, 0.1 ml of Triton X-100 (0.05%) was injected in the heart through a needle inserted in the output cannula in the ventricle, avoiding damage of the atrium (for protocol details see Ref. 21 ). Subsequently, variables of cardiac performance were measured after 20 min of perfusion with the saline.
To investigate the role of the ET AR and ETBR subtypes in mediation of the effects of ET-1 or Cts, cardiac preparations were pretreated with either 1 M of BQ-123, an antagonist of the ET AR, or 1 M of BQ-788, an antagonist of ETBR. Subsequently, the hearts were perfused with Ringer solution containing increasing concentrations of ET-1 (from 0.01 to 10 nM) or Cts (from 11 to 110 nM), with and without supplementation of BQ-123 or BQ-788. The time exposure to each drug concentration was 10 -15 min.
The effects of Cts on ET-1-mediated cardiac effects.
To analyze the effects of Cts on the ET-1 response, Cts-stimulated hearts (110 nM) were perfused with increasing concentrations of ET-1 (from 0.01 to 1 nM) both in presence or absence of BQ-788. The time exposure to each drug concentration was 10 -15 min.
Statistics. All data are expressed as means Ϯ SE. Curve fitting was accomplished in the program Kaleidagraph (Synergy Software, Reading, PA). The EC 50 values of a peptide were interpolated as the concentration that achieved 50% stimulation. For analysis of phosphorylated proteins, levels were quantified using Bio-Rad QuantifyOne, and the volumes of phosphorylated proteins were divided by the levels of nonphosphorylated proteins to calculate the degree of activation. Stimulation of protein activity was expressed as fold increase over the vehicle-treated control. Multiple comparisons between groups were made using either one-way ANOVA followed by Bonferroni's post hoc test or two-way ANOVA. Statistical significance was concluded at P Ͻ 0.05. Statistics were computed with the program InStat (GraphPad Software, San Diego, CA).
RESULTS
Basal Conditions
As previously described (21, 51) , the in vitro isolated, perfused whole frog heart preparation generates cardiac hemodynamic responses that mimic those obtained in vivo. After 20 min of equilibration, the following basal recordings were obtained: SV ϭ 1.9 Ϯ 0.1 ml/kg, SW ϭ 3.5 Ϯ 0.2 mJ/g, HR ϭ 59.6 Ϯ 1.8 beat/min, preload ϭ 1.6 Ϯ 0.1 mmHg, afterload ϭ 27.0 Ϯ 0.3 mmHg, and CO ϭ 112.5 Ϯ 2.3 ml⅐min Ϫ1 ⅐kg Ϫ1 .
Influence of Cts on Myocardial Performance
Cts concentrations ranging from 11 to 165 nM caused a concentration-dependent decrease in both SV and SW that reached a maximum reduction of ϳ20% at 165 nM of Cts (Fig. 1A) . A significant 7.3% decrease of SV was induced by 33 nM of Cts (Fig. 1A) . 
Signaling Mechanisms by Which Cts Modulates Cardiac Function
It is known that both PLN and ERK1/2 are involved in the coordination of cardiac contraction and relaxation and that they are expressed in frog heart (56, 19, 3, 4) . Therefore, we checked whether Cts modulates PLN and ERK1/2. Cts inhibited phosphorylation of PLN at the protein kinase A specific site, Ser 16 (by ϳ50%; Fig. 1B) , and augmented phosphorylation of ERK1/2 (by ϳ53%; Fig. 1C ). These effects were modified by BQ-788 (ET BR antagonist) but not by BQ-123 (ET AR antagonist), suggesting an involvement of ET BR in Cts signaling to cardiac function (Fig. 1, B and C) . The involvement of the NO-cGMP pathway in the Cts-mediated depression of SV has been demonstrated. In fact, we found that the negative inotropic effects of Cts (110 nM) were abolished by pretreatment with either NOS (L-NMMA; 10 M) or guanylate cyclase (ODQ; 10 M) inhibitors ( Fig. 2A) . In addition, the EE integrity is necessary for the cardioinhibitory action of Cts because functional damage of the EE with Triton X-100 (0.05%) abrogated this effect ( Fig. 2A) . We have previously shown that L-NMMA, ODQ, and Triton X-100 alone cause significant increments in SV and SW (21, 51) .
The role of the ET R subtypes in the Cts response (11, 33, 65 , and 110 nM) was also analyzed. Although the pretreatment with ET AR inhibitor (BQ-123; 1 M) failed to modify the negative inotropism of Cts at all concentration tested, BQ-788 (1 M), the ET BR antagonist, completely blocked this response (Fig. 2B ). At the concentration tested, ET receptor antagonists alone did not induce significant changes on SV (1.08 Ϯ 0.66 for BQ-788 and Ϫ2.37 Ϯ 1.15 for BQ-123).
Cts Modulation of ISO-Induced Cardiac Changes
Cardiac frog preparations exposed to ISO (10 nM) confirmed the classical positive inotropic response (21, 49) as reflected by significant increments in SV (by 10.3%; Fig. 3 ). Although the low dose of Cts (33 nM) failed to inhibit the ISO-induced increase in SV, Cts at higher concentrations of 65 and 110 nM completely abolished the ISO-mediated increase of SV (Fig. 3) . Cts failed to inhibit the ISO-induced response in the presence of ET BR antagonist (Fig. 3) .
The antagonistic effect of Cts (33, 65, and 110 nM) toward the ISO (from 0.1 to 1,000 nM)-mediated increase in cardiac function was investigated. ISO alone caused a concentrationdependent increment in SV (Fig. 4) (Fig. 4) .
Concentration-Dependent Effects of ET-1 in the Frog Heart
Exposure of the isolated heart to ET-1 alone caused a dose-dependent biphasic effect on cardiac function. ET-1 exerted both negative and positive inotropic effects as documented by changes in SV (Fig. 5) . Although the low dose of ET-1 (0.01 nM) always caused a negative inotropic effect (ϳ8%), the higher concentrations of ET-1 (0.1-10 nM) triggered either the negative (50% preparations; by Ϫ7.9 to Ϫ11%) or positive (50% preparations; by ϳ7 to ϳ10%) inotropic effects. Pretreatment with L-NMMA (10 M) or ODQ (10 M) completely abolished the ET-1 (0.01 nM)-induced negative inotropic effects (Fig. 6A) . Negative inotropic effects of a low dose of ET-1 (0.01 nM) were also abolished by the damage of the EE with Triton X-100 (0.05%) (Fig. 6A) . In contrast, the positive inotropic effects caused by higher doses of ET-1 (1 nM) remained unaffected by pretreatment with L-NMMA ( Fig. 6B) . Hence, we did not pursue the effects of ODQ and Triton X-100 on the positive inotropic effects of ET-1.
Chemical blockade of the ET AR by BQ-123 caused complete inhibition of the positive inotropic effects of ET-1 (0.1-10 nM) (Fig. 7A) . After chemical inhibition of ET AR , ET-1 exerted only the negative inotropic effects through the unopposed ET BR (Fig. 7A) . In contrast, the chemical inhibition of ET BR by BQ-788 inhibited the negative inotropic effects of ET-1 at all doses tested. In the absence of ET BR , ET-1 induced only the positive inotropic effects (0.1-10 nM) through the unopposed ET AR (Fig. 7B) .
Cts-ET-1 Interaction
Cts (110 nM) completely abolished the positive inotropic effects of ET-1 on SV (0.1-1 nM) but did not modulate ET-1's negative inotropic effects on SV, indicating that ET-1 and Cts act through a convergent signaling pathway to exert the latter effect (Fig. 7C) . Interestingly, Cts failed to abolish ET-1's positive inotropic effects in the presence of the ET BR antagonist BQ-788 (Fig. 7C) . These findings point out that Cts activates the ET BR to antagonize the positive inotropic effects of ET-1 on SV (Fig. 7C) .
DISCUSSION
Cts and Basal Mechanical Performance
It is well established that Cts acts as an endogenous noncompetitive antagonist of nicotine-evoked catecholamine secretion from rat PC-12 or bovine chromaffin cells (36 -39) . Cts was also shown to act as a potent in vivo vasodilator by stimulating histamine release through H 1 receptor activation (26) . Furthermore, clinical and human studies indicated that Cts may function as an antihypertensive agent (44), whereas, on the contrary, nothing is known about its direct effects on myocardial physiology.
We used the avascular frog heart, which is exclusively supplied from the luminal (lacunae) blood, to investigate Cts' direct myocardiotropic action in the absence of coronary reactivity. At the same time, this natural heart model is ideally suited for analyzing the distinct paracrine role of the EE in the signal transduction of blood-borne chemical stimuli (exogenous Cts) targeting the heart. The isolated and perfused heart, working at physiological loads, showed a cardiac performance stable for Ͼ1 h, as indicated by typical time course experiments (21) . With this preparation, we demonstrated that Cts dose-dependently modulates the basal mechanical performance of the isolated working frog heart, acting as a direct cardiodepressing peptide. Because preliminary experiments revealed the absence of desensitization, concentration-response curves were generated.
We recently demonstrated that peptides derived from the NH 2 terminus of CgA (VS-1-related fragments) exert notable cardiosuppressive action on the isolated rat, frog, and eel hearts (17, 25, 16) . It is interesting to note that amphipathic VS-1 and amphiphilic Cts peptides, representing the NH 2 -and COOHterminal domains of CgA, respectively, exhibit analogous negative contractile responses at similar concentrations, reaching a maximum (by ϳ20%) reduction of SV and SW. Despite the analogous cardiosuppressive effects of both VS-1 and Cts, only Cts was able to rescue Chga null mice from high blood pressure (34) . Thus these results further document that CgA, as being the precursor of cardioactive peptides, modulates the mechanical performance of the heart under nonstimulated conditions. In the present study, Cts causes marked reduction in SV with an EC 50 ϳ50 nM. In normotensive individuals, circulating Cts (ϳ1.5-2 nmol/l) is inversely proportional to intact CgA (ϳ5-10 nmol/l) (44) . Because CgA and CgAderived fragments are expressed in rat heart tissue extracts (23) and in human ventricular myocardium (46) , the local concentration of Cts in the myocardium may reach 50 nM and regulate cardiac function in an autocrine/paracrine manner. transients (22) . Furthermore, phosphorylation of ERKs is implicated in mediating the cardiac contractile response (12) . In the isolated perfused frog heart, ERKs are reported to be activated in response to pressure overload (3) or in response to ␣ 1 -and ␤-adrenoceptor stimulation (4). Therefore, the interaction between Cts and PLN and/or ERK1/2 may be of potential interest in relation to further work on Cts-induced changes of cardiac contractility.
Signaling Mechanisms of Cts Modulation
Here we demonstrate that Cts directly inhibits PLN-Ser 16 and augments P-ERK1/2 levels. It may be postulated that the Cts-mediated increment in P-ERK1/2 levels led to the stimulation of endothelial NOS (eNOS) with consequent production of NO (Fig. 8) . In fact, a recent work (45) suggests that ERK1/2 directly activates the NO signal transduction pathway. Another study (58) suggested an interaction between ET BR and ERK at the level of the caveolae. At present, the receptor that mediates the effects of Cts on the heart is unknown. However, we postulate that Cts mediates its effects through a G proteincoupled ET BR (see Fig. 8 for putative mechanisms of action).
This hypothesis is supported by our results in which the inhibitory and stimulatory effects of Cts on PLN and ERK1/2, respectively, appear mediated by ET BR , but not by ET AR , receptors.
In the frog heart, we have previously demonstrated the presence of a constitutive NOS (eNOS) located within EE, the only barrier between the cardiac lumen and the subjacent myocardium (51). The EE is able to modulate ventricular performance under both basal (i.e., nonstimulated) (51) and chemically (i.e., cholinergic)-stimulated conditions (21) through a NO-cGMP signaling pathway. In the present study, we found that Cts-mediated negative inotropism is abolished by pretreatment with NOS or guanylate cyclase inhibitors, consistent with Cts-induced stimulation of the NO-cGMP pathway. In addition, the results obtained with Triton X-100, which made EE dysfunctional (10, 21) , implicated an EE-mediated mechanism in Cts signaling transduction. Notably, this contrasts with the VS-1-induced negative inotropism reported in the frog heart, which, unlike the pattern demonstrated in eel and rat hearts (25, 13) , involved neither the EE nor the G protein nor the NO-cGMP-protein kinase G mechanism (17) . Therefore, the signal transduction mechanisms underlying the cardiosuppressive action of the two CgA-derived peptides are not identical. As discussed later, the question remains open as to how and why an amphipathic peptide VS-1 and an amphiphilic peptide Cts, representing NH 2 -and COOH-terminal domains of CgA, respectively, utilize divergent signaling pathways to converge on their effects on cardiosuppression. The analogous effects of VS-1 and Cts on cardiosuppression raise the intriguing question regarding the biological significance of such apparently redundant molecular strategy. Further studies will clarify whether, behind this similarity, the two peptides may subserve subtly different functions, e.g., summation and synergism, or distinct spatiotemporal compartmentation (celland tissue-specific proteolytic processing and release).
Cts and ISO Signaling
Loewi (32) initially described adrenergic regulation of cardiac contractility in the denervated frog heart using Accellerans-Stoff or Sympathin, which was later identified as epinephrine (31) . It has long been known that epinephrine is the predominant neurotransmitter in the frog heart, and in frog plasma under resting conditions it is five times more concentrated than norepinephrine; the latter, however, may increase considerably under stress, following release from the adrenal medulla (6) . In excessive amounts, these two endogenous catecholamines are well known to be cardiotoxic for both amphibian and mammalian (including human) hearts, since they induce dose-dependent myocardial lesions. For example, exogenous ISO has been frequently used to produce myocardial necrosis both in frog (14) and mammalian hearts (47) .
In a previous study, it has been established that ISO induces positive inotropic responses in frog heart via ␤-adrenergic receptors (49) . In this work, the complete inhibition of ISO (10 nM)-induced positive inotropic effects by Cts indicates that Cts is acting as an antiadrenergic peptide, and Cts signaling pathways dominate over the adrenergic one. The costimulation experiments with both Cts and ISO in the presence of BQ-788 reinforce the hypothesis that Cts mediates its dominant antiadrenergic action through the activation of the ET BR . Because the concentration-dependent positive inotropism of ISO failed to overcome the inhibitory effects of Cts on positive response, we concluded that the Cts inhibition of ISO is noncompetitive. Interestingly, the Cts-mediated inhibition of nicotine-evoked catecholamine secretion is also noncompetitive (39, 36, 33) . Similar to Cts, analogous antiadrenergic actions of several CgA NH 2 -terminal fragments have been demonstrated in frog, eel, and rat hearts (17, 25, 16) . Tota and coworkers (54) also reported that the homologous frog CgA peptides (CgA [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] and CgA [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] ) are able to counteract the positive inotropism exerted by ISO in the frog heart. Thus, in addition to the pharmacological implications of our data, it is possible to hypothesize that the autocrine-paracrine role of Cts, as well as of the other CgA-derived peptides, may play a physiological role acting as a natural protective mechanism against excessive adrenergic stimulation.
ET-1-Cts Interaction
ETs are essential physiological regulators of normal cardiac and vascular functions, and an excessive generation or activity of ETs has been linked to several cardiovascular pathologies, including hypertension (9) . The recent finding that human CHGA gene influences endothelial ET-1 secretion in vivo suggests an interaction between the sympatochromaffin system and the endothelium (29) .
In the present study, we have demonstrated that ET-1 induces negative inotropism at lower concentrations (0.01 nM). In contrast, higher concentrations of ET-1 (0.1-10 nM) induced both positive (50% of hearts) and negative inotropism (50% of hearts). In mammals, either positive or negative inotropic responses of ET-1 have been reported in cardiac preparations of different species and experimental models (cell, tissue, organ). For example, in whole cardiac preparations, the effects of ET are often complicated by concomitant influences of coronary perfusion (9) . By using the avascular frog heart, we analyzed the direct myocardial effects of ET-1 independently from the coronary-induced changes occurring in coronary-supplied hearts. The findings that L-NMMA, ODQ, and Triton X-100 completely abolished the negative inotropic effects of ET-1 indicate that ET-1 utilizes the functionally intact EE and the NO-cGMP pathway to exert its negative inotropic effects.
The ET-1 actions occur via G protein-coupled ET AR and ET BR subtypes. Although vascular smooth muscle cells, cardiomyocytes, fibroblasts, hepatocytes, and neurons express ET AR , ET BR are mainly expressed in endothelial and vascular smooth muscle cells. ET-1 binding to ET AR activates phospholipase C (PLC), leading to the generation of inositol trisphosphate, which in turn stimulates intracellular calcium release (43) (Fig. 8) (30) . In our preparations, the chemical blockade of ET AR by BQ-123 completely inhibited ET-1-induced positive inotropic effects, suggesting that ET-1 utilizes the ET AR to exert its positive inotropic effects. However, BQ-123 failed to inhibit the negative inotropic effect of ET-1 at a concentration of 0.01 nM, indicating that ET-1, at this concentration, acts exclusively through the ET BR . Interestingly, since after chemical blockade of ET AR , ET-1 exerted only negative inotropism, we suggest that ET-1 action via ET BR could now act unopposed without the influence of the ET AR . Furthermore, inhibition of the ET BR by BQ-788 completely inhibited the negative (0.01-10 nM) inotropic effects of ET-1 that appear mediated by NO and an intact EE. Of note, our results agree with a recent study (28) that demonstrated, in rabbit papillary muscles, that higher concentrations (10 Ϫ9 M) of ET-1 produced a sustained positive inotropic effect, whereas the negative inotropic effect was observed only when ET-1 was given in the presence of an ET AR antagonist. In addition, the same study demonstrated that negative inotropism induced by ET BR stimulation is EE and NO dependent.
In the frog heart, Cts blocked ET-1's positive, but not the negative, inotropic effects. Because BQ-788, but not BQ-123, completely abolished Cts' negative inotropic effects, we can conclude that Cts acts through ET BR (Fig. 8) . It is interesting to note that, while Cts acts through ET BR to exert its negative inotropic effect, it completely abolished ET-1's positive inotropic effect mediated via ET AR . This indicates that activation of ET BR by Cts dominates over the activation of ET AR by ET-1. Cts action through ET BR was reinforced when Cts failed to inhibit ET-1-induced positive inotropism in the presence of BQ-788. The demonstration that Cts is able to counteract the stimulatory influence of ET-1 may represent another potentially beneficial attribute of this CgA-derived peptide.
Significance of Two Cardioactive Peptides in one Precursor
The analogous cardiosuppressive effects of VS-1 and Cts raise the question regarding the biological significance of two peptides processed from one precursor. Further studies will clarify whether, behind such apparently redundant molecular strategy, there is an advantage of having two peptides regulating the same physiological response. Because of coordinate actions, they may act on overlapping or different sites, subserving subtly different functions, e.g., summation and synergism, or distinct spatiotemporal compartmentation (cell-and tissue-specific proteolytic processing and release). With specific reference to cardiovascular prohormones, an example is provided by the two peptide hormones processed from the pro-atrial natriuretic peptide (ANP) precursor, i.e., vessel dilator and ANP (55), both showing vasodilatory, diuretic, and natriuretic properties.
Conclusions
The avascular frog heart, used as bioassay to investigate the role of EE-dependent transduction of the ET-1 and Cts endoluminal stimuli, has contributed to reveal the importance of this tissue in mediating the interaction between the sympatochromaffin system and the myocardium. Should this mechanism be experimentally extended to the mammalian heart, it could contribute to account for the antihypertensive effects of Cts. In conclusion, the present study suggests a novel paracrine/autocrine role of Cts in the frog heart, since Cts depresses cardiac function and inhibits both ␤-adrenergic and ET-1-elicited stimuli. These Cts' cardiotropic features could be homeostatically relevant, particularly under stress conditions, when the heart becomes a preferential target of both adrenergic and endothelin stimuli, thus emphasizing the concept of "zero steady-state error" homeostasis proposed for other CgAderived peptides (27) .
